drugset / Trial / NCT00655980

Summary

In this study, we want to find out if laughing gas (nitrous oxide) leads to a higher rate of cardiac complications after surgery in patients with a specific genetic profile (mutations in the MTHFR gene) and if this risk can be prevented by giving patients vitamin B12 and folate during surgery.

Timeline

Start
2008-02
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nitrous Oxide Other / unclassified
Subject Vitamin B12 Other / unclassified 1 mg Intravenous
Subject folic acid Other / unclassified 5 mg Intravenous